Neuropathic pain is associated with elevated IL-1β, IL-6, IL-17, and TNF-α. Therapies for neuropathic pain that modify the levels of cytokines have potential. Further studies should investigate how efficacious these medications are for neuropathic pain. The gene discussed is IL1B; the disease is neuropathic pain.